Search Results - "WALLACE, DARREN P"
-
1
PKD1 and PKD2 mRNA cis-inhibition drives polycystic kidney disease progression
Published in Nature communications (15-08-2022)“…Autosomal dominant polycystic kidney disease (ADPKD), among the most common human genetic conditions and a frequent etiology of kidney failure, is primarily…”
Get full text
Journal Article -
2
Retinoic acid signaling pathways in development and diseases
Published in Bioorganic & medicinal chemistry (15-01-2014)“…This graphical abstract represents the chemical structures of retinoic acid and several synthetic derivative retinoids, the use of these chemicals for probing…”
Get full text
Journal Article -
3
microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism
Published in Nature communications (16-02-2017)“…Autosomal dominant polycystic kidney disease (ADPKD) is the most frequent genetic cause of renal failure. Here we identify miR-17 as a target for the treatment…”
Get full text
Journal Article -
4
Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease
Published in The Journal of clinical investigation (01-06-2015)“…Autosomal dominant polycystic kidney disease (ADPKD) is characterized by renal cyst formation, inflammation, and fibrosis. Macrophages infiltrate cystic…”
Get full text
Journal Article -
5
Epithelial Vasopressin Type-2 Receptors Regulate Myofibroblasts by a YAP-CCN2-Dependent Mechanism in Polycystic Kidney Disease
Published in Journal of the American Society of Nephrology (01-08-2020)“…Fibrosis is a major cause of loss of renal function in autosomal dominant polycystic kidney disease (ADPKD). In this study, we examined whether vasopressin…”
Get full text
Journal Article -
6
MicroRNA-21 Aggravates Cyst Growth in a Model of Polycystic Kidney Disease
Published in Journal of the American Society of Nephrology (01-08-2016)“…Autosomal dominant polycystic kidney disease (ADPKD), one of the most common monogenetic disorders, is characterized by kidney failure caused by bilateral…”
Get full text
Journal Article -
7
Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin
Published in American journal of physiology. Renal physiology (01-11-2011)“…In autosomal dominant polycystic kidney disease (ADPKD), arginine vasopressin (AVP) accelerates cyst growth by stimulating cAMP-dependent ERK activity and…”
Get more information
Journal Article -
8
The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease
Published in Cell death & disease (14-10-2021)“…Autosomal-dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease and is characterized by progressive growth of fluid-filled…”
Get full text
Journal Article -
9
Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease
Published in Scientific reports (20-02-2018)“…Polycystic kidney disease (PKD) is a genetic disorder characterized by fluid-filled cysts in the kidney and liver that ultimately leads to end-stage renal…”
Get full text
Journal Article -
10
Increased water intake decreases progression of polycystic kidney disease in the PCK rat
Published in Journal of the American Society of Nephrology (01-08-2006)“…Renal enlargement in polycystic kidney disease (PKD) is caused by the proliferation of mural epithelial cells and transepithelial fluid secretion into the…”
Get full text
Journal Article -
11
Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells
Published in Journal of the American Society of Nephrology (2006)“…Polycystic kidney disease (PKD) is a lethal disorder characterized by progressive expansion of renal cysts. Genetic mutations associated with PKD are thought…”
Get full text
Journal Article -
12
Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease
Published in Journal of the American Society of Nephrology (01-04-2016)“…cAMP stimulates cell proliferation and Cl(-)-dependent fluid secretion, promoting the progressive enlargement of renal cysts in autosomal dominant polycystic…”
Get full text
Journal Article -
13
-
14
Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease
Published in Kidney international (01-04-2014)“…In renal cystic diseases, sustained enlargement of fluid-filled cysts is associated with severe interstitial fibrosis and progressive loss of functioning…”
Get more information
Journal Article -
15
Tubular Obstruction Leads to Progressive Proximal Tubular Injury and Atubular Glomeruli in Polycystic Kidney Disease
Published in The American journal of pathology (01-07-2014)“…In polycystic kidney disease (PKD), renal parenchyma is destroyed by cysts, hypothesized to obstruct nephrons. A signature of unilateral ureteral obstruction,…”
Get full text
Journal Article -
16
Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells
Published in American journal of physiology. Renal physiology (01-11-2010)“…In autosomal dominant polycystic kidney disease (ADPKD), aberrant proliferation of the renal epithelial cells is responsible for the formation of numerable…”
Get more information
Journal Article -
17
Ouabain promotes partial epithelial to mesenchymal transition (EMT) changes in human autosomal dominant polycystic kidney disease (ADPKD) cells
Published in Experimental cell research (15-06-2017)“…The hormone ouabain has been shown to enhance the cystic phenotype of autosomal dominant polycystic kidney disease (ADPKD). Among other characteristics, the…”
Get full text
Journal Article -
18
Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype
Published in The Journal of biological chemistry (24-09-2004)“…cAMP can be either mitogenic or anti-mitogenic, depending on the cell type. We demonstrated previously that cAMP inhibited the proliferation of normal renal…”
Get full text
Journal Article -
19
Prospects for mTOR Inhibitor Use in Patients with Polycystic Kidney Disease and Hamartomatous Diseases
Published in Clinical journal of the American Society of Nephrology (01-07-2010)“…Mammalian target of rapamycin (mTOR) is the core component of two complexes, mTORC1 and mTORC2. mTORC1 is inhibited by rapamycin and analogues. mTORC2 is…”
Get full text
Journal Article -
20
Osteopontin deletion attenuates cyst growth but exacerbates fibrosis in mice with cystic kidney disease
Published in Physiological reports (01-09-2024)“…Osteopontin (OPN) is a multi‐functional glycoprotein that coordinates the innate immune response, prevents nanocrystal formation in renal tubule fluid, and is…”
Get full text
Journal Article